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Conclusion: A novel, next-generation anthropomorphic 
phantom allows a versatile SBRT QA, by assessing high dose 
target coverage and simultaneous OAR dose or peripheral 
lung dose in an end-to-end testing setup hereby including 
inter-fraction rotations. The phantom will be the basis of a 
multi-center peer-to-peer institutional audit of thoracic 
IMRT/VMAT and SBRT. 
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Purpose or Objective: Stereotactic radiotherapy requires 
detectors capable of determining the delivered dose with 
high accuracy. The aim of this study is to characterize the 
performance of a new unshielded silicon diode prototype, the 
IBA Razor, for dose measurements in small radiation therapy 
photon beams in flattening filter free (FFF) mode 
 
Material and Methods: The performance of the newly 
commercialized stereotactic diode was evaluated relative to 
that of the previously available SFD diode and the PFD 
detectors, both from IBA. The Razor is made with an n-type 
implant in p-type silicon. The active volume is 0.6mm in 
diameter and 20µm in length. The detector response stability 
in measured dose, dose rate and dose per pulse were 
evaluated. Dark current as function of the received dose was 
also evaluated. The detector response in square fields, in the 
range from 0.8 to 5.0 cm, was evaluated by means of 
percentage depth dose curves (PDDs), axial beam profiles and 
output factors. 
 
Results: The short term stability of the Razor was found to 
be much improved relative to the SFD, exhibiting a variation 
of less than ±0.1% for a dose of 1.2 kGy delivered in a single-
session. Dose linearity showed a deviation of less than ±1% in 
the 0.05–30 Gy range and a dose rate dependence of less than 
±0.5% in the 4–24 Gy/min range. The dose per pulse 
dependence, evaluated in the 0.08-0.21 cGy/pulse range, 
was found to be within ±0.8%. A larger dark current with 
increase in dose was observed for the Razor with values of 
0.0025pA/Gy compared to the 0.0002pA/Gy for the SFD. This 
characteristic is attributed to an increased concentration of 
the recombination centers and can be practically solved by 
resetting the background before every acquisition.  
The measured PDDs agreed to within 1% with those obtained 
using the PFD detector. The profile analysis showed good 
results as long as a background correction was applied before 
each profile acquisition: penumbra differences were below 
±0.3 mm relative to PFD, with a slight overestimation of the 
tails (<1%), due to the absence of the shielding. When 
background correction was not applied regularly, larger 
differences were observed in the low dose penumbra region 
and in the profile tails, probably due to the higher dark 
current. Output factors were in good agreement with those 
measured by the PFD detector to within 1% for fields up to 
5x5 cm2, for larger fields the absence of the shielding in the 
stereotactic detector led to differences >2%. 
 
Conclusion: The new IBA Razor unshielded diode replaces the 
IBA SFD, with the additional advantages of improved stability 
(up to 1.2 kGy) compared to the reference stereotactic 
diode. The Razor has the same high spatial resolution and 
performance in small radiation fields. These features make 
the Razor diode detector a good candidate for radiation 
therapy and in small field dosimetry to support advanced 
radiation therapy techniques. 
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Purpose or Objective: In this study, a delivery quality 
assurance (DQA) method was designed to overcome the 
limitations of the conventional DQA process in the static 
condition for internal target volume (ITV)-based VMAT. The 
dynamic DQA measurement device was designed with a 
moving phantom that can simulate variable target motions. 
The dose distribution in the real volume of the target and 
OARs were reconstructed with the measurement data under 
the dynamic condition. Then, to evaluate the designed DQA 
method, the dose-volume histogram (DVH) data of the real 
target and OARs were compared with the DVHs calculated in 
the ITV-based VMAT plan. 
 
Material and Methods: The dynamic DQA measurement 
device was designed with a moving phantom that can 
simulate variable target motions. The dose distribution in the 
real volume of the target and organ-at-risk (OAR)s were 
reconstructed using 3DVH with the ArcCHECK measurement 
data under the dynamic condition. A total of 10 ITV-based 
RapidArc plans for liver-cancer patients were analyzed with 
